Sobrevivente desde 2007
I tracked down this information via Breastcancer.org.
This drug is one of the RANKL inhibitors which blocks the RANKL protein. It limits the activity level of certain bone cells, called osteoclasts, which can cause bone weakening and damage that can happen when breast cancer spreads to the bone. RANKL inhibitors also can help keep blood calcium levels normal. This is important because bone damage may increase blood calcium. It is probably tracked via blood tests. Usually with drugs, they have to build up in your system for them to start working. Your oncologist will probably be the best person to talk with. Him and your blood levels will be able to give you answers specific to your body. Hang in there and take care, Sharon